1. Home
  2. Health
  3. Haryana government decides to halt production of cough syrups by Maiden Pharmaceuticals

Haryana government decides to halt production of cough syrups by Maiden Pharmaceuticals

The Haryana government has to take a decision to halt the production of cough syrup made by drug company Maiden Pharmaceuticals after a joint scrutiny by the Central and State Drug Departments found 12 shortcomings with the medication.

By wasmulhaq 
Updated Date

Chandigarh: The Haryana government has to take a decision to halt the production of cough syrup made by drug company Maiden Pharmaceuticals after a joint scrutiny by the Central and State Drug Departments found 12 shortcomings with the medication. The World Health Organization (WHO) previously reported that the cough syrups may have contributed to the deaths of 66 children in the Gambia.

Also Read :- Drug Board launches investigation following WHO warning about cold and cough syrups that killed 66 children in Gambia

According to Haryana Home Minister Anil Vij, “After the Central and Haryana State Drug Departments conducted a joint inspection, around 12 defects were detected. Keeping this in mind, it has been determined that the entire manufacturing unit will be stopped.

“Sonipat’s pharmaceutical company sent samples of three of the WHO-recommended medications to the Central Drug Laboratory in Kolkata. Action will be taken after the unveiling of the reports, which have not come yet, he said.

The WHO recently issued a warning amid concerns over four cough syrups manufactured in Haryana’s Sonepat. The cough syrup manufactured by a Sonepat-based drug company is allegedly linked with the acute kidney injuries that killed 66 children in the African nation of Gambia.

WHO’s laboratory makes it clear that four cough syrups confirm that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.

Further reading:
For the latest news and reviews, follow us on Facebook, YouTube and Twitter पर फॉलो करे...